SurgerySpO2NCT07313488
Oxygen Saturation Monitoring During Transport Between the Operating Room and the Post-anesthesia Care Unit
An observational study of Surgery, run by University Hospital, Strasbourg, France at 1 site in France.
Trial summary
To evaluate whether continuous SpO₂ monitoring during transfer between the operating room and the Post-Anesthesia Care Unit (PACU) reduces the incidence of desaturations Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Surgery
- How many people
- 30 participants
- Where
- 1 siteFrance
- Study dates
- 20 May 2025to Feb 2026
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Adult patient (≥ 18 years old) scheduled for surgery under general anesthesia at the HUS between January 1, 2024 and April 30, 2025
Who may be able to join
- Adult patient (≥ 18 years old)
- Patient scheduled for surgery under general anesthesia at the HUS between January 1, 2024 and April 30, 2025
Who cannot join
- Administration of premedication that may impair judgment.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
France1 site, 1 recruiting
- Recruiting
Service d'Anesthésie - CHU de Strasbourg - France
Strasbourg, 67091
Vincent MATEO, MD, 33 3 69 55 00 87, vincent.mateo@chru-strasbourg.fr
Vincent MATEO, MD
About this study
To evaluate whether continuous SpO₂ monitoring during transfer between the operating room and the Post-Anesthesia Care Unit (PACU) reduces the incidence of desaturations
- Conditions
- Surgery
- Keywords
- Surgery, Oxygen saturation monitoring
What is being measured
The primary outcome is the main question the study is designed to answer.
Reduction of the incidence of desaturations
To evaluate whether continuous SpO₂ monitoring during transfer between the operating room and the PACU reduces the incidence of desaturations by recording:
- The last SpO₂ reading taken upon leaving the operating room
- The first SpO₂ reading taken upon arrival in the recovery room
- The lowest SpO₂ reading taken during the transfer between the operating room and the recovery room (for patients monitored by pulse oximetry)
Measured: upon Arrival in the Recovery Room
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted2 Jan 2026
- Study start20 May 2025
- Primary completionFeb 2026 (estimated)
- Study completionFeb 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for SurgeryStudies of the same condition, open and under way.
- More trials run by University Hospital, Strasbourg, FranceThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Retrospective
- Enrolment
- 30 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University Hospital, Strasbourg, France
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07313488
- Sponsor's protocol ID
- 9538
- Acronym
- SpO2
- Status last verified
- Dec 2025
- First submitted
- 17 Dec 2025
- Last updated
- 2 Jan 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 2 Jan 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Oxygen Saturation Monitoring During Transport Between the Operating Room and the Post-anesthesia Care Unit
- ClinicalTrials.gov ID
- NCT07313488
- Acronym / sponsor ID
- SpO2 / 9538
- Conditions
- Surgery
- Keywords
- Surgery, Oxygen saturation monitoring
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 30 participants (estimated)
- Lead sponsor
- University Hospital, Strasbourg, FranceUniversity, hospital or other
- Study start
- 20 May 2025 (actual)
- Primary completion
- Feb 2026 (estimated)
- Study completion
- Feb 2026 (estimated)
- First posted
- 2 Jan 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
To evaluate whether continuous SpO₂ monitoring during transfer between the operating room and the Post-Anesthesia Care Unit (PACU) reduces the incidence of desaturations
Study design
- Observational model
- Case only
- Time perspective
- Retrospective
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Adult patient (≥ 18 years old) scheduled for surgery under general anesthesia at the HUS between January 1, 2024 and April 30, 2025
Key inclusion criteria (2 listed)
- Adult patient (≥ 18 years old)
- Patient scheduled for surgery under general anesthesia at the HUS between January 1, 2024 and April 30, 2025
Key exclusion criteria (1 listed)
- Administration of premedication that may impair judgment.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Reduction of the incidence of desaturations
Time frame: upon Arrival in the Recovery Room
To evaluate whether continuous SpO₂ monitoring during transfer between the operating room and the PACU reduces the incidence of desaturations by recording: * The last SpO₂ reading taken upon leaving the operating room * The first SpO₂ reading taken upon arrival in the recovery room * The lowest SpO₂ reading taken during the transfer between the operating room and the recovery room (for patients monitored by pulse oximetry)
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 2 Jan 2026.
Related trials for Surgery
Active, not recruiting
Shockwave™ vs Surgical Endarterectomy for Calcified Severe Common Femoral Artery Stenosis: Comparison of Efficacy, Safety and Long-Term Outcomes
Common Femoral Artery Stenosis, Calcification; Heart
RecruitingObservational study
Comparison of Hemodynamic Responses During Anesthesia Induction Using Eleveld and Schnider
Spinal (Fusion) Surgery, Total Intravenous Anesthesia
RecruitingPhase 1
Serial Amnioinfusions as Regenerative Therapy for Pulmonary Hypoplasia
Renal Failure Congenital, Congenital Renal Anomaly Nos
RecruitingPhase 2
Proton Spatially Fractionated Radiotherapy or Photon Stereotactic Body Radiotherapy in Combination With Pembrolizumab Before Surgery for the Treatment of Locally Advanced and Radiation-Naive Locoregionally Recurrent Oral Cavity Cancer, OSPRI Trial
Locally Advanced Oral Cavity Squamous Cell Carcinoma, Locally Recurrent Oral Cavity Squamous Cell Carcinoma
RecruitingPhase 2/3
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
Muscle Invasive Bladder Urothelial Carcinoma, Muscle Invasive Renal Pelvis Urothelial Carcinoma
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Surgery, run by University Hospital, Strasbourg, France at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 2 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Vincent MATEO, MD (33 3 69 55 00 87, vincent.mateo@chru-strasbourg.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Reduction of the incidence of desaturations (time frame: upon Arrival in the Recovery Room). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Jan 2026.